Friday, December 3, 2010

Biorepositories Asia Session Spotlight: Gain Regulatory Insights for Clinical Trials in China

Leading up to Biorepositories Asia, we'll be highlighting a session from the upcoming conference. It will take place April 11-13, 2011, in San Francisco, California. For more information, download the brochure.

Featured Session: Gain Regulatory Insights for Clinical Trials in China
Presenters: Christopher Hickey, Country Director, U.S. FDA, PEOPLE’S REPUBLIC OF CHINA (Invited)
Yi Chengdong, MD, PhD, Deputy Director General, SHANGHAI FDA (Invited)

About the session:
To address the growing biopharma presence in Asia, the U.S. FDA has opened offices overseas and is increasingly collaborating with its counterparts in these countries including China and India. Hear directly from the regulatory experts on these collaborative efforts and the impact on the biopharma industry including:
• Expectations for future collaborations
• Insights to regulatory challenges in these regions
• Insights to the importation and exportation of samples in and out
of China

Share this article with your social network, just click below to share now!

No comments :

Post a Comment